Annual Operating Expenses
$30.29 B
+$9.15 B+43.26%
December 1, 2024
Summary
- As of March 6, 2025, ABBV annual total operating expenses is $30.29 billion, with the most recent change of +$9.15 billion (+43.26%) on December 1, 2024.
- During the last 3 years, ABBV annual operating expenses has risen by +$9.47 billion (+45.45%).
- ABBV annual operating expenses is now at all-time high.
Performance
ABBV Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$12.20 B
+$5.86 B+92.52%
December 1, 2024
Summary
- As of March 6, 2025, ABBV quarterly total operating expenses is $12.20 billion, with the most recent change of +$5.86 billion (+92.52%) on December 1, 2024.
- Over the past year, ABBV quarterly operating expenses has stayed the same.
- ABBV quarterly operating expenses is now at all-time high.
Performance
ABBV Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ABBV Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.3% | 0.0% |
| 3 y3 years | +45.5% | 0.0% |
| 5 y5 years | +135.8% | 0.0% |
ABBV Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.5% | at high | +155.7% |
| 5 y | 5-year | at high | +135.8% | at high | +344.8% |
| alltime | all time | at high | +499.1% | at high | +647.9% |
AbbVie Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $30.29 B(+43.3%) | $12.20 B(+92.5%) |
| Sep 2024 | - | $6.33 B(+19.0%) |
| Jun 2024 | - | $5.33 B(+1.4%) |
| Mar 2024 | - | $5.25 B(-10.9%) |
| Dec 2023 | $21.15 B(-6.1%) | $5.90 B(+15.8%) |
| Sep 2023 | - | $5.09 B(+5.4%) |
| Jun 2023 | - | $4.83 B(-9.2%) |
| Mar 2023 | - | $5.32 B(-2.3%) |
| Dec 2022 | $22.52 B(+8.1%) | $5.45 B(+5.1%) |
| Sep 2022 | - | $5.19 B(-27.1%) |
| Jun 2022 | - | $7.12 B(+49.3%) |
| Mar 2022 | - | $4.77 B(-13.2%) |
| Dec 2021 | $20.83 B(+9.3%) | $5.49 B(-2.7%) |
| Sep 2021 | - | $5.65 B(+13.0%) |
| Jun 2021 | - | $5.00 B(+6.4%) |
| Mar 2021 | - | $4.69 B(-13.4%) |
| Dec 2020 | $19.05 B(+48.3%) | $5.42 B(+17.9%) |
| Sep 2020 | - | $4.60 B(-22.9%) |
| Jun 2020 | - | $5.96 B(+93.9%) |
| Mar 2020 | - | $3.07 B(+12.1%) |
| Dec 2019 | $12.84 B(-31.1%) | $2.74 B(-30.4%) |
| Sep 2019 | - | $3.94 B(+29.8%) |
| Jun 2019 | - | $3.04 B(-2.8%) |
| Mar 2019 | - | $3.12 B(-64.2%) |
| Dec 2018 | $18.65 B(+60.4%) | $8.72 B(+169.1%) |
| Sep 2018 | - | $3.24 B(-9.5%) |
| Jun 2018 | - | $3.58 B(+15.4%) |
| Mar 2018 | - | $3.10 B(-15.6%) |
| Dec 2017 | $11.63 B | $3.68 B(+36.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $2.69 B(-2.5%) |
| Jun 2017 | - | $2.75 B(+9.5%) |
| Mar 2017 | - | $2.52 B(-14.1%) |
| Dec 2016 | $10.47 B(-3.3%) | $2.93 B(+14.1%) |
| Sep 2016 | - | $2.57 B(-3.5%) |
| Jun 2016 | - | $2.66 B(+15.1%) |
| Mar 2016 | - | $2.31 B(-17.8%) |
| Dec 2015 | $10.82 B(-10.7%) | $2.81 B(-2.8%) |
| Sep 2015 | - | $2.89 B(+6.8%) |
| Jun 2015 | - | $2.71 B(+12.3%) |
| Mar 2015 | - | $2.41 B(-49.2%) |
| Dec 2014 | $12.12 B(+41.9%) | $4.75 B(+60.1%) |
| Sep 2014 | - | $2.96 B(+29.0%) |
| Jun 2014 | - | $2.30 B(+8.8%) |
| Mar 2014 | - | $2.11 B(-7.9%) |
| Dec 2013 | $8.54 B(+6.1%) | $2.29 B(+4.5%) |
| Sep 2013 | - | $2.19 B(+0.5%) |
| Jun 2013 | - | $2.19 B(+16.8%) |
| Mar 2013 | - | $1.87 B(-11.7%) |
| Dec 2012 | $8.05 B(-12.3%) | $2.12 B(+11.7%) |
| Sep 2012 | - | $1.90 B(-5.0%) |
| Jun 2012 | - | $2.00 B(-2.0%) |
| Mar 2012 | - | $2.04 B(-21.1%) |
| Dec 2011 | $9.19 B(+38.6%) | $2.58 B(-19.4%) |
| Sep 2011 | - | $3.21 B(+96.6%) |
| Jun 2011 | - | $1.63 B(-7.6%) |
| Mar 2011 | - | $1.77 B |
| Dec 2010 | $6.63 B(+31.1%) | - |
| Dec 2009 | $5.06 B | - |
FAQ
- What is AbbVie annual total operating expenses?
- What is the all time high annual operating expenses for AbbVie?
- What is AbbVie annual operating expenses year-on-year change?
- What is AbbVie quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AbbVie?
- What is AbbVie quarterly operating expenses year-on-year change?
What is AbbVie annual total operating expenses?
The current annual operating expenses of ABBV is $30.29 B
What is the all time high annual operating expenses for AbbVie?
AbbVie all-time high annual total operating expenses is $30.29 B
What is AbbVie annual operating expenses year-on-year change?
Over the past year, ABBV annual total operating expenses has changed by +$9.15 B (+43.26%)
What is AbbVie quarterly total operating expenses?
The current quarterly operating expenses of ABBV is $12.20 B
What is the all time high quarterly operating expenses for AbbVie?
AbbVie all-time high quarterly total operating expenses is $12.20 B
What is AbbVie quarterly operating expenses year-on-year change?
Over the past year, ABBV quarterly total operating expenses has changed by $0.00 (0.00%)